Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report.
Yuta IbeRyuichiro KakizakiHirotoshi InamuraTomoyuki IshigoYoshihiro FujiyaHiroyuki InoueShuji UemuraSatoshi FujiiSatoshi TakahashiEichi NarimatsuMasahide FukudoPublished in: Journal of pharmaceutical health care and sciences (2023)
TAZ/CTLZ and low-dose TOB combination therapy showed the potential for synergistic effects. Our present report suggests a novel synergistic treatment strategy for rare cases that are refractory to the treatment of infections, such as XDR-P. aeruginosa infection.